Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fulcrum Therapeutics

6.88
+0.28004.24%
Post-market: 6.880.00000.00%16:21 EDT
Volume:1.04M
Turnover:7.13M
Market Cap:371.38M
PE:-837.90
High:7.06
Open:6.69
Low:6.31
Close:6.60
Loading ...
Aug 11, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2020

Major Issues Report

8-K - Current report
Jul 23, 2020

Major Issues Report

8-K - Current report
Jun 26, 2020

Major Issues Report

8-K - Current report
Jun 24, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jun 22, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Jun 11, 2020

Major Issues Report

8-K - Current report
Jun 10, 2020

Major Issues Report

8-K - Current report
May 13, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2020

Major Issues Report

8-K - Current report
Apr 02, 2020

Major Issues Report

Current report, item 8.01
Mar 05, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Mar 05, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 05, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 20, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 05, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 05, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals